Clinical Trial Alerts – December 2018
Cystic Fibrosis Foundation distributed the following clinical trial update in December. Click the trial title to get more details.
Description: This trial will look at the safety and effectiveness of the drug MS1819 as a pancreatic enzyme replacement therapy.
Age: 18 Years and Older
Mutation: No Mutation Requirement
Fev1% Predicted: 30% or greater
Number of Visits: 10
Length of Participation: 11 weeks
ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT03746483